Aprio Wealth Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$650K Buy
3,009
+159
+6% +$30.4K 0.03% 324
2026
Q1
$522K Buy
2,850
+900
+46% +$166K 0.03% 338
2025
Q4
$343K Buy
+1,950
New +$319K 0.02% 404

Other funds holding BIIB

Aprio Wealth Management's BIIB Position: Q2 2026 in Review

Aprio Wealth Management increased its Biogen (BIIB) stake by 5.6% in Q2 2026, buying an estimated $30.4K and bringing the position to 3,009 shares worth $650K. The position accounts for 0.03% of the portfolio, ranked #324.

Aprio Wealth Management first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. 269 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Aprio Wealth Management held 3,009 shares of Biogen worth $650K as of Q2 2026.
  • Aprio Wealth Management bought 159 Biogen shares in Q2 2026, an estimated $30.4K.
  • Biogen made up 0.03% of Aprio Wealth Management's portfolio in Q2 2026, its #324 holding.
  • Aprio Wealth Management first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
  • 269 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Aprio Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.